Abstract
In our previous study, we have shown that number of synapses in the L5 segment of spinal dorsal horn increased significantly in a rat model of painful diabetic neuropathy (PDN) induced by high-dose of streptozotocin (an animal model of type 1 diabetes). The aims of this study were: (1) to determine whether high fat diet/low dose streptozotocin-diabetes, a rat model for type 2 diabetes, related PDN was also associated with this synaptic plasticity, (2) to reveal the range of this synaptic plasticity change occurred (in the whole length of spinal dorsal horn or only in the L5 lumbar segment of spinal dorsal horn) and (3) to discover whether treatment with metformin had effect on this synaptic plasticity. Male adult Sprague–Dawley rats were randomly allocated into the control group (n = 7), the PDN group (n = 6) and the PDN treated with metformin (PDN + M) group (n = 7), respectively. 28 days after medication, synaptic and neuronal numbers in the whole length of spinal dorsal horn or in 1 mm length of the L5 segment of spinal dorsal horn were estimated by the optical disector (a stereological technique). Compared to the control group and the PDN + M group, number of synapses in the L5 segment of spinal dorsal horn increased significantly in the PDN group (P < 0.05). There was no significant change between the control group and the PDN + M group in terms of the parameters in the L5 segment of the spinal dorsal horn (P > 0.05). Parameters of the whole length of spinal dorsal horn showed no significant changes (P > 0.05). Our results suggest that high fat diet/low dose streptozotocin diabetes related PDN is also associated with a numerical increase of synapses in the L5 segment of spinal dorsal horn but not in the whole length of spinal dorsal horn. Furthermore, the analgesic effect of metformin against PDN is related to its inhibition of numerical increase of synaptic number in the rat spinal dorsal horn.
Similar content being viewed by others
References
Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM et al (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology 43(4):817–824
Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM (2015) Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes 6(3):432–444
Peltier A, Goutman SA, Callaghan BC (2014) Painful diabetic neuropathy. BMJ 348:g1799
Bastyr EJ 3rd, Price KL, Bril V, MBBQ Study Group (2005) Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther 27(8):1278–1294
Zieglar D, Gries FA, Spüler M, Lessmann F (1992) The epidemiology of diabetic neuropathy. Diabetic cardiovascular autonomic neuropathy multicenter study group. J Diabetes Complicat 6(1):49–57
Fuchs D, Birklein F, Reeh PW, Sauser SK (2010) Sensitized peripheral nociception in experimental diabetes of the rat. Pain 151(2):496–505
Lin J-Y, Huang X-L, Chen J, Yang Z-W, Lin J, Huang S, Peng B (2017) Stereological study on the number of synapses in the rat spinal dorsal horn with painful diabetic neuropathy induced by streptozotocin. Neuroreport 28(6):319–324
Callaghan BC, Little AA, Feldman EL, Hughes RA (2012) Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 13(6):CD007543
Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M (1995) Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333(2):89–94
Mao-Ying QL, Kavelaars A, Krukowski K et al (2014) The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model. PLoS ONE 9(6):e100701
Ma J, Yu H, Liu J et al (2015) Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin. Eur J Pharmacol 764:599–606
Taylor A, Westveld AH, Szkudlinska M et al (2013) The use of metformin is associated with decreased lumbar radiculopathy pain. J Pain Res 6:755–763
Russe OQ, Möser CV, Kynast KL et al (2013) Activation of the AMP-activated protein kinase reduces inflammatory nociception. J Pain 14(11):1330–1340
Łabuzek K, Liber S, Suchy D, Okopień B (2013) A successful case of pain management using metformin in a patient with adiposis dolorosa. Int J Clin Pharmacol Ther 51(6):517–524
Zuo ZF, Wang W, Niu L et al (2011) RU486 (mifepristone) ameliorates cognitive dysfunction and reverses the down-regulation of astrocytic N-myc downstream-regulated gene2 in streptozotocin-induced type-1 diabetic rats. Neuroscience 190:156–165
Kou ZZ, Li CY, Tang J et al (2013) Down-regulation of insulin signaling is involved in painful diabetic neuropathy in type 2 diabetes. Pain Physician 16(2):E71–E83
Chen SR, Pan HL (2002) Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats. J Neurophysiol 87(6):2726–2733
Mei XP, Zhou Y, Wang W et al (2011) Ketamine depresses toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain. Neurosignals 19(1):44–53
Chaplan SR, Bach FW, Pogrel JW et al (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53(1):55–63
Peng B, Lin JY, Shang Y et al (2010) Plasticity in the synaptic number associated with neuropathic pain in the rat spinal dorsal horn: a stereological study. Neurosci Lett 486(1):24–28
Morrow TJ (2004) Animal models of painful diabetic neuropathy: the STZ rat model. Curr Protoc Neurosci. https://doi.org/10.1002/0471142301.ns0918s29. (Chap. 9:Unit 9.18).
Gheibi S, Kashfi K, Ghasemi A (2017) A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin. Biomed Pharmacother 95:605–613. https://doi.org/10.1016/j.biopha.2017.08.098
Lin JY, Peng B, Yang ZW, Min S (2011) Number of synapses increased in the rat spinal dorsal horn after sciatic nerve transection: a stereological study. Brain Res Bull 84(6):430–433
Zhou X, Wu LF (2003) Spinal cord. In: Cheng LZ, Zhong CP, Cai WQ (eds) Contemporary histology. Shanghai Scientific and Technological Literature Publishing House, Shanghai, pp 425–427 (book in Chinese)
Gundersen HJ, Bagger P, Bendtsen TF et al (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96(10):857–881
Martin MM (1953) Diabetic neuropathy; a clinical study of 150 cases. Brain 76(4):594–624
Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P et al (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33(10):2285–2293
Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC (1998) Smallfiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 44(1):47–59
Shehab SA (2009) Acute and chronic sectioning of fifth lumbar spinal nerve has equivalent effects on the primary afferents of sciatic nerve in rat spinal cord. J Comp Neurol 517(4):481–492
Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ (2011) Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabetes Care 34(10):2220–2224
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977–986
Linn T, Ortac K, Laube H, Federlin K (1996) Intensive therapy in adult insulin dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomized, controlled, prospective study over 5 years in newly diagnosed patients. Metabolism 45(12):1508–1513
Azad N, Emanuele NV, Abraira C, Henderson WG, Colwell J, Levin SR et al (1999) The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complicat 13(5–6):307–313
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360(2):129–139
Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM et al (2010) Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376(9739):419–430
Tovi J, Svanborg E, Nilsson BY, Engfeldt P (1998) Diabetic neuropathy in elderly type 2 diabetic patients: effects of insulin treatment. Acta Neurol Scand 98(5):346–353
Melemedjian OK, Khoutorsky A, Sorge RE, Yan J, Asiedu MN et al (2013) mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK. Pain 154(7):1080–1091
Melemedjian OK, Yassine HN, Shy A, Price TJ (2013) Proteomic and functional annotation analysis of injured peripheral nerves reveals ApoE as a protein upregulated by injury that is modulated by metformin treatment. Mol Pain 9:14
Acknowledgements
We thank Guoyun Qin, Buming Wan, Shuai He and Mingyou Wang (undergraduates of North Sichuan Medical College) for their assistance in the lab work and animal care.
Funding
This research was supported by the Grant of the Education Department of Sichuan (No. 16ZA0238) and the Grant from Special Project of Municipal-school Cooperation (NSMC20170443).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lin, Jy., He, Yn., Zhu, N. et al. Metformin attenuates increase of synaptic number in the rat spinal dorsal horn with painful diabetic neuropathy induced by type 2 diabetes: a stereological study. Neurochem Res 43, 2232–2239 (2018). https://doi.org/10.1007/s11064-018-2642-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-018-2642-4